1. Home
  2. SOL vs NSPR Comparison

SOL vs NSPR Comparison

Compare SOL & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emeren Group Ltd each representing 10 shares

SOL

Emeren Group Ltd each representing 10 shares

HOLD

Current Price

$1.94

Market Cap

98.5M

Sector

Technology

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.94

Market Cap

81.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOL
NSPR
Founded
2005
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
81.8M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SOL
NSPR
Price
$1.94
$1.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$4.50
$4.50
AVG Volume (30 Days)
270.2K
101.5K
Earning Date
11-14-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$71,226,000.00
$7,779,000.00
Revenue This Year
N/A
$22.76
Revenue Next Year
$45.37
$75.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.04
52 Week Low
$1.04
$1.59
52 Week High
$2.30
$3.80

Technical Indicators

Market Signals
Indicator
SOL
NSPR
Relative Strength Index (RSI) 68.41 47.60
Support Level $1.89 $1.74
Resistance Level $1.95 $2.00
Average True Range (ATR) 0.05 0.12
MACD 0.02 0.01
Stochastic Oscillator 96.54 48.72

Price Performance

Historical Comparison
SOL
NSPR

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: